Nanoray-312: phase III study of NBTXR3 + radiotherapy ± cetuximab in elderly, platinum-ineligible locally advanced HNSCC
Jinming Yu, Zoltán Takácsi‐Nagy, S. Thureau, Kiran Devisetty et al.
Citations
10 citations
Journal
Future Oncology
Topics
Lung Cancer Diagnosis and Treatment
Field-Weighted Citation Impact (FWCI)
15.18
article
Nanoray-312: phase III study of NBTXR3 + radiotherapy ± cetuximab in elderly, platinum-ineligible locally advanced HNSCC
Jinming Yu, Zoltán Takácsi‐Nagy, S. Thureau, Kiran Devisetty, Caroline Hoffmann, X. Liem, Maria Lesnik, France Nguyen, Martin Burian, Omar I. Vivar, Laetitia Finzi, Anaïs Debard, Sandra Nuyts, Eter Natelauri, Amanda Psyrri, Christophe Le Tourneau, Leonard A. Farber, Trevor Hackman, Sue S. Yom, Feng Liu
article en
10 citations
Abstract
No abstract available for this paper.
Publication Tag
Future OncologyVol. 21(12)
Institutions
Semmelweis University (HU), University of North Carolina at Chapel Hill (US), University of California, San Francisco (US), National and Kapodistrian University of Athens (GR), Cancer Institute (WIA) (IN), Nanobiotix (France) (FR), Institut Gustave Roussy (FR), Shandong Tumor Hospital (CN), Laboratoire d'Informatique, du Traitement de l'Information et des Systèmes (FR), Johnson & Johnson (Sweden) (SE), Hunan Cancer Hospital (CN), Centre Oscar Lambret (FR), AGO Austria (AT), Shandong First Medical University (CN), Université de Rouen Normandie (FR), Institut Curie (FR)